Repros Therapeutics (RPRX) Reports Q4 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.52 --0%
Financial Fact:
General and administrative: 997K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
General and administrative: 997K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.16), versus ($0.26) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Getty Realty (GTY) Reiterated at Market Outperform by Citizens on Investment Volumes
- Ennis (EBF) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
